Dr. Zaid Saheb Mohammed Sedaai
Specialist — Internal Medicine & Pulmonology
- MB ChB
About Dr. Zaid
Dr. Zaid is a Specialist in Internal Medicine and Pulmonology at Muscat Private Hospital, where he has practised since September 2016. With more than 20 years of clinical experience across Syria and Oman, he is dual-trained in general internal medicine and respiratory medicine, and manages the full spectrum of adult medical conditions — from diabetes, hypertension and cholesterol disorders to asthma, chest infections and complex respiratory disease.
He graduated in Medicine and Surgery from the Medical College of Damascus University in 2003. He was awarded the Syrian Board of Internal Medicine in 2008 and the Syrian Board in Respiratory Medicine in 2012, each accompanied by a Specialty Certificate from the Ministry of Health with a “very good” rating. He has been licensed by the Oman Ministry of Health as a Specialist in Internal Medicine since 2014.
Dr. Zaid’s earlier career spanned some of Damascus’s principal teaching and referral hospitals, including the Red Crescent Hospital, Damascus Central Hospital, Ibn Al-Nafis Hospital and Al Assad University Hospital, where he worked across internal medicine, coronary care, renal and haematology services, and the pulmonary department. He served in the intensive care units at the Red Crescent Hospital and Daria Hospital, designated centres during the H1N1 swine flu pandemic, and later, at Muscat Private Hospital, was the lead physician responsible for complicated COVID-19 patients through 2020 and 2021.
His interventional practice centres on bronchoscopy and bronchial procedures, CT-guided lung biopsy and fine-needle aspiration, and pleural and pulmonary biopsy, supported by pulmonary function testing and expertise in invasive and non-invasive ventilation. He also runs a medically supervised weight-management service for patients with obesity and related metabolic conditions.
An active contributor to continuing medical education, Dr. Zaid has spoken at Muscat Private Hospital’s cardiology and internal medicine symposia and attends respiratory, diabetes and endocrine meetings across the Gulf and internationally. He is known for a patient-centred, communicative approach and consults in both Arabic and English.
Conditions Treated
Diabetes and pre-diabetes
Hypertension (high blood pressure)
Hyperlipidaemia (high cholesterol) and metabolic syndrome
Obesity and weight-related medical conditions
Bronchial asthma
Chronic obstructive pulmonary disease (COPD)
Pneumonia and chest infections
Chronic cough
Breathlessness and reduced exercise tolerance
Fever
Acute and chronic, including fever of unknown origin
Obstructive sleep apnoea and sleep-disordered breathing
Pleural disease, including pleural effusion
Respiratory diseases in general
General adult internal medicine conditions and multi-system disease
Procedures & Services
Bronchoscopy and bronchial interventions
Bronchial, pleural and pulmonary biopsy
CT-guided lung biopsy (true-cut) and fine-needle aspiration (FNA)
Pulmonary function tests (lung function testing)
Assessment and management of sleep apnoea
Non-invasive ventilation
BiPAP and CPAP
Invasive ventilation, intubation and extubation in critical care
Central venous line insertion (jugular and subclavian)
Cardiac stress testing
ECG, chest X-ray and chest CT interpretation
Cardiopulmonary resuscitation (CPR) and acute medical emergencies
Comprehensive laboratory services
Comprehensive radiology services
Medically Supervised Weight Management
Dr. Zaid runs a non-surgical weight-loss service for adults with obesity or weight-related conditions such as type 2 diabetes, hypertension, high cholesterol and obstructive sleep apnoea. Care begins with a full medical assessment
History, examination, laboratory testing and screening for underlying causes and complications — followed by an individualised plan combining dietary, activity and behavioural changes with medical therapy where it is clinically appropriate.
Where medication is indicated, this may include injectable GLP-1 receptor agonist and dual GIP/GLP-1 receptor agonist therapies
Semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro). These are prescription-only medicines: they are started only after assessment, at a dose titrated to the individual patient, and continued under regular review of tolerability, side effects and progress alongside management of any co-existing conditions.
These treatments are not suitable for everyone, and are prescribed only where clinically appropriate following a full medical assessment. Results vary between individuals.
Professional Experience
Specialist, Internal Medicine
Muscat Private Hospital (JCI accredited), Muscat, Oman (September 2016 – Present); lead physician for complicated COVID-19 patients, 2020–2021
- November 2014 – September 2016
Specialist, Internal Medicine
Al Aqsa Specialized Medical Complex, Oman
- April – December 2012
Pulmonary Department
Ibn Al-Nafis Hospital, Ministry of Health, Syria
- September 2011 – April 2012
Pulmonary Department and pulmonary interventions
Al Assad University Hospital, Damascus, Syria
- February 2010 – September 2011
Internal Medicine, Pulmonary Department and Intensive Care Unit
Ibn Al-Nafis Hospital, Ministry of Health, Syria
- August 2009 – January 2010
Internal Medicine and Intensive Care during the H1N1 pandemic
Daria Hospital and Duma Hospital, Ministry of Health, Damascus countryside, Syria
- March 2008 – May 2012
Internal Medicine Specialist, supervising coronary care patients
Al Safa Hospital (private), Syria
- April – August 2006
Internal Medicine, Renal Diseases and Haematology Departments
Damascus Central Hospital, Ministry of Health, Syria
- June 2003 – April 2006; and August 2006 – December 2007
Internal Medicine Department, Coronary Care Unit and Internal Medicine Clinic
Al Hilal Al Ahmar (Red Crescent) Hospital, Ministry of Health, Damascus, Syria
Education & Training
Bachelor of Medicine and Surgery
Medical College, Damascus University, Syria
December 2003Specialty Certificate in Internal Medicine, Ministry of Health (very good rating), and Syrian Board of Internal Medicine
January 2008Subspecialty in Pulmonary Medicine
Specialty Certificate in Pulmonology, Ministry of Health (very good rating), and Syrian Board in Respiratory Medicine
December 2012Licensed Specialist in Internal Medicine
Ministry of Health, Oman
since 2014; current and validBLS and ACLS certification
2017, renewed 2019Diabetes Management course
Leicester Diabetes Centre, UK
2019Primary Care Preceptorship Programme
Cleveland Clinic
2019Intensive Diabetes Care Programme
under the Oman Diabetes Association
2026Dr. Zaid maintains an active programme of continuing medical education and has spoken at several Muscat Private Hospital symposia. Selected highlights:
Speaker
MPH Cardiology Symposium
2018 and September 2019Speaker
MPH Internal Medicine Symposium
Gulf COPD and Asthma Symposium (2019); 2nd Gulf Respiratory District
2023Dubai International Asthma and COPD Forum
2017 and 2018Oman Thoracic (2017); Management of TB workshops
2017AACE Fourth Comprehensive Endocrine Course, Muscat (2018); AACE Gulf
2019MSD Cardio-Metabolic Summit
2019MBRACE, Istanbul (2018); NCPI Conference for Internal Diseases, Antalya, Turkey
2010Training courses in pulmonary medicine
Syrian Medical Association
2010–2012A full list of courses, conferences and certificates is available on request.
Frequently Asked Questions
Book Your Consultation with
Dr. Zaid in Muscat
Book your consultation with Dr. Zaid in Muscat, Oman. Our team is here to help you arrange the right appointment.
Prefer to speak with us? Call Dr. Zaid and our team will assist with appointment availability and insurance enquiries.